Ascendis Pharma A (ASND) Capital Expenditures Growth (3y) (2015 - 2024)
Ascendis Pharma A (ASND) Capital Expenditures Growth (3y) (2015 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2024 |
66.24% |
| Jun 30, 2024 |
55.97% |
| Mar 31, 2024 |
64.56% |
| Dec 31, 2023 |
-88.30% |
| Sep 30, 2023 |
42.84% |
| Jun 30, 2023 |
54.25% |
| Mar 31, 2023 |
44.41% |
| Dec 31, 2022 |
-33.50% |
| Sep 30, 2022 |
-31.86% |
| Jun 30, 2022 |
-124.91% |
| Mar 31, 2022 |
-15.15% |
| Dec 31, 2021 |
116.05% |
| Sep 30, 2021 |
-115.17% |
| Jun 30, 2021 |
-120.97% |
| Mar 31, 2021 |
-238.38% |
| Dec 31, 2020 |
179.35% |
| Sep 30, 2020 |
-242.04% |
| Jun 30, 2020 |
-180.53% |
| Mar 31, 2020 |
-156.51% |
| Dec 31, 2019 |
96.48% |
